"- The treatment must be clinically appropriate and safe, which implies it should have necessary regulatory authorization (e.g., MHRA approval for medicines or medical devices) before it can be considered for NHS funding via an IFR.
- NHS IFR policies explicitly state that funding approval must be obtained prior to treatment commencing, and treatments without regulatory approval would generally not be considered appropriate or safe to fund."
So we have approval, but it hasn't been announced yet??
Market Data 
Markets 
AI
